{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T12:11:59Z","timestamp":1785499919800,"version":"3.56.0"},"reference-count":19,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,3,5]],"date-time":"2018-03-05T00:00:00Z","timestamp":1520208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec><jats:title>Aims and hypothesis<\/jats:title><jats:p>Hypoxic-ischemic encephalopathy (HIE) remains an important cause of death and disability in newborns. Mild therapeutic hypothermia (TH) is safe and effective; however, there are no tissue biomarkers available at the bedside to select babies for treatment. The aim of this study was to show that it is feasible to study plasma neurofilament light (NfL) levels from newborns and to evaluate their temporal course. Hypothesis: Raised plasma NFL protein levels from newborns who undergo TH after HIE are associated with abnormal MRI outcomes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Between February 2014 and January 2016, term newborns with HIE treated with TH for 72\u2009h had plasma samples taken at three time points: (i) after the infant had reached target temperature, (ii) prior to commencing rewarming, and (iii) after completing rewarming. Infants with mild HIE who did not receive TH had a single specimen taken. NfL protein was analyzed using an enzyme-linked immunosorbent assay.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Twenty-six newborns with moderate\u2013severe HIE treated with TH were studied. Half of these had cerebral MRI predictive of an unfavorable outcome. Plasma NfL levels were significantly higher in the TH group with unfavorable outcome (median age 18\u2009h) compared to levels from both the mild HIE group and TH group with favorable outcome (<jats:italic>F<\/jats:italic>\u2009=\u200925.83, <jats:italic>p<\/jats:italic>\u2009&amp;lt;\u20090.0001). Newborns who had MRIs predictive of unfavorable outcome had significantly higher NfL levels compared to those with favorable outcomes, at all three time points (mixed models, <jats:italic>F<\/jats:italic>\u2009=\u200927.63, <jats:italic>p<\/jats:italic>\u2009&amp;lt;\u20090.001). A cutoff NfL level &amp;gt;29\u2009pg\/mL at 24\u2009h is predictive of an unfavorable outcome [sensitivity 77%, specificity 69%, positive predictive value (PPV) 67%, negative predictive value (NPV) 72%] with increasing predictive value until after rewarming (sensitivity 92%, specificity 92%, PPV 92%, NPV 86%).<\/jats:p><\/jats:sec><jats:sec><jats:title>Interpretation of research<\/jats:title><jats:p>Plasma NfL protein levels may be a useful biomarker of unfavorable MRI outcomes in newborns with moderate\u2013severe HIE and may assist in selecting newborns for adjunctive neuroprotective interventions. Larger studies with NfL testing at earlier time points are required.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fneur.2018.00086","type":"journal-article","created":{"date-parts":[[2018,3,5]],"date-time":"2018-03-05T04:21:06Z","timestamp":1520223666000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":27,"title":["Raised Plasma Neurofilament Light Protein Levels Are Associated with Abnormal MRI Outcomes in Newborns Undergoing Therapeutic Hypothermia"],"prefix":"10.3389","volume":"9","author":[{"given":"Divyen K.","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vennila","family":"Ponnusamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Evanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Kapellou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Ekitzidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neelam","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adina T.","family":"Michael-Titus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping K.","family":"Yip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,3,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1136\/bmj.317.7172.1554","article-title":"Antepartum risk factors for newborn encephalopathy: the Western Australian case-control study","volume":"317","author":"Badawi","year":"1998","journal-title":"BMJ"},{"key":"B2","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1080\/01443610020025967","article-title":"The relationships between neonatal encephalopathy and cerebral palsy: a cohort study","volume":"21","author":"Evans","year":"2001","journal-title":"J Obstet Gynaecol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"c363","DOI":"10.1136\/bmj.c363","article-title":"Neurological outcomes at 18 months of age after moderate hypothermia for perinatal hypoxic ischaemic encephalopathy: synthesis and meta-analysis of trial data","volume":"340","author":"Edwards","year":"2010","journal-title":"BMJ"},{"key":"B4","doi-asserted-by":"publisher","first-page":"CD003311","DOI":"10.1002\/14651858.CD003311.pub3","article-title":"Cooling for newborns with hypoxic ischaemic encephalopathy","volume":"1","author":"Jacobs","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"B5","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1056\/NEJMoa1315788","article-title":"Effects of hypothermia for perinatal asphyxia on childhood outcomes","volume":"371","author":"Azzopardi","year":"2014","journal-title":"N Engl J Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1056\/NEJMoa1112066","article-title":"Childhood outcomes after hypothermia for neonatal encephalopathy","volume":"366","author":"Shankaran","year":"2012","journal-title":"N Engl J Med"},{"key":"B7","volume-title":"UK TOBY Cooling Register Clinician\u2019s Handbook","author":"Azzopardi","year":"2010"},{"key":"B8","doi-asserted-by":"publisher","first-page":"144","DOI":"10.3389\/fneur.2012.00144","article-title":"Biomarkers of hypoxic-ischemic encephalopathy in newborns","volume":"3","author":"Douglas-Escobar","year":"2012","journal-title":"Front Neurol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e20160659","DOI":"10.1542\/peds.2016-0659","article-title":"Early EEG grade and outcome at 5 years after mild neonatal hypoxic ischemic encephalopathy","volume":"138","author":"Murray","year":"2016","journal-title":"Pediatrics"},{"key":"B10","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.jns.2005.03.015","article-title":"Neurofilament phosphoforms: surrogate markers for axonal injury, degeneration and loss","volume":"233","author":"Petzold","year":"2005","journal-title":"J Neurol Sci"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1212\/WNL.0000000000001642","article-title":"Neurofilament light chain: a prognostic biomarker in amyotrophic lateral sclerosis","volume":"84","author":"Lu","year":"2015","journal-title":"Neurology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1136\/jnnp-2013-307454","article-title":"Serum neurofilament light chain is a biomarker of human spinal cord injury severity and outcome","volume":"86","author":"Kuhle","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e75091","DOI":"10.1371\/journal.pone.0075091","article-title":"Increased neurofilament light chain blood levels in neurodegenerative neurological diseases","volume":"8","author":"Gaiottino","year":"2013","journal-title":"PLoS One"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1111\/j.1651-2227.2001.tb03249.x","article-title":"Brain-specific proteins in the cerebrospinal fluid of severely asphyxiated newborn infants","volume":"90","author":"Blennow","year":"2001","journal-title":"Acta Paediatr"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14767058.2017.1344964","article-title":"Increase of neuronal injury markers Tau and neurofilament light proteins in umbilical blood after intrapartum asphyxia","author":"Toorell","year":"2017","journal-title":"J Matern Fetal Neonatal Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.clp.2013.09.004","article-title":"Pharmacologic neuroprotective strategies in neonatal brain injury","volume":"41","author":"Juul","year":"2014","journal-title":"Clin Perinatol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S1474-4422(09)70295-9","article-title":"Assessment of brain tissue injury after moderate hypothermia in neonates with hypoxic-ischaemic encephalopathy: a nested substudy of a randomised controlled trial","volume":"9","author":"Rutherford","year":"2010","journal-title":"Lancet Neurol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1001\/jamaneurol.2016.5905","article-title":"Neurofilament protein and antineurofilament antibodies following traumatic brain injury-reply","volume":"74","author":"Shahim","year":"2017","journal-title":"JAMA Neurol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e0132177","DOI":"10.1371\/journal.pone.0132177","article-title":"Comparative assessment of the prognostic value of biomarkers in traumatic brain injury reveals an independent role for serum levels of neurofilament light","volume":"10","author":"Al Nimer","year":"2015","journal-title":"PLoS One"}],"updated-by":[{"DOI":"10.3389\/fneur.2024.1474489","type":"corrigendum","label":"Corrigendum","source":"publisher","updated":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T00:00:00Z","timestamp":1727654400000}}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2018.00086\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T15:28:34Z","timestamp":1727710114000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2018.00086\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,5]]},"references-count":19,"alternative-id":["10.3389\/fneur.2018.00086"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2018.00086","relation":{"corrigendum":[{"id-type":"doi","id":"10.3389\/fneur.2024.1474489","asserted-by":"object"}]},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,5]]},"article-number":"86"}}